Human platelet gel supernatant inactivates opportunistic wound pathogens on skin

Platelets

Volumn 26, Issue 1, 2015, Pages 13-16

  Edelblute, Chelsea M ^a   Donate, Amy L ^a   Hargrave, Barbara Y ^a,b   Heller, Loree C ^a,b  

^a OLD DOMINION UNIVERSITY   (United States)

^b OLD DOMINION UNIVERSITY   (United States)

Author keywords

Acinetobacter baumannii; Platelet gel; Platelet rich plasma; Pseudomonas aeruginosa; Staphylococcus aureus

Indexed keywords

ANTIBIOTIC AGENT;

ACINETOBACTER BAUMANNII; ANIMAL EXPERIMENT; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BROTH DILUTION; CONTROLLED STUDY; EX VIVO STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RAT; SKIN; SKIN DECONTAMINATION; SKIN INJURY; STAPHYLOCOCCUS AUREUS; SUPERNATANT; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE RICH PLASMA; WOUND HEALING; ANIMAL; BACTERIAL INFECTIONS; DISEASE MODEL; INJURIES; METABOLISM; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; OPPORTUNISTIC INFECTIONS; WOUNDS AND INJURIES;

ACINETOBACTER BAUMANNII; BACTERIA (MICROORGANISMS); PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS;

ACINETOBACTER BAUMANNII; ANIMALS; BACTERIAL INFECTIONS; BLOOD PLATELETS; DISEASE MODELS, ANIMAL; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; OPPORTUNISTIC INFECTIONS; PLATELET-RICH PLASMA; PSEUDOMONAS AERUGINOSA; RATS; SKIN; STAPHYLOCOCCUS AUREUS; WOUND HEALING; WOUNDS AND INJURIES;

EID: 84921459232     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.3109/09537104.2013.863859     Document Type: Article

References (43)

1. Everts PA, Knape JT, Weibrich G, Schonberger JP, Hoffmann J, Overdevest EP, Box HA, van Zundert A. Platelet-rich plasma and platelet gel: A review. J Extra Corpor Technol 2006;38: 174-187.
2. Zhang J, Blackmore PF, Hargrave BY, Xiao S, Beebe SJ, Schoenbach KH. Nanosecond pulse electric field (nanopulse): Anovel non-ligand agonist for platelet activation. Arch Biochem Biophys 2008;471:240-248.
3. Italiano Jr JE, Battinelli EM. Selective sorting of alpha-granule proteins. Journal of thrombosis and haemostasis: JTH 2009;7: 173-176.
4. Blair P, Flaumenhaft R. Platelet alpha-granules: Basic biology and clinical correlates. Blood Rev 2009;23:177-189.
5. Everts PA, Hoogbergen MM, Weber TA, Devilee RJ, van Monftort G, de Hingh IH. Is the use of autologous platelet-rich plasma gels in gynecologic, cardiac, and general, reconstructive surgery beneficial? Curr Pharm Biotechnol 2012;13:1163-1172.
6. Lubkowska A, Dolegowska B, Banfi G. Growth factor content in PRP and their applicability in medicine. J Biol Regul Homeost Agents 2012;26:3S-22S.
7. Sommeling CE, Heyneman A, Hoeksema H, Verbelen J, Stillaert FB, Monstrey S. The use of platelet-rich plasma in plastic surgery: A systematic review. J PlastReconstr Aesth Surg JPRAS 2013;66: 301-311.
8. Whitman DH, Berry RL, Green DM. Platelet gel: An autologous alternative to fibrin glue with applications in oral and maxillofacial surgery. J Oral Maxillofac Surg 1997;55:1294-1299.
9. Bava ED, Barber FA. Platelet-rich plasma products in sports medicine. Physician Sportsmed 2011;39:94-99.
10. Stanco D, Vigano M, Croiset SJ, De Girolamo L. Applications and limits of platelet-rich plasma in sports related injuries. J Biol Regul Homeost Agents 2012;26:53S-61S.
11. Lacci KM, Dardik A. Platelet-rich plasma: Support for its use in wound healing. Yale J Biol Med 2010;83:1-9.
12. Carter MJ, Fylling CP, Parnell LK. Use of platelet rich plasma gel on wound healing: A systematic review and meta-analysis. Eplasty 2011;11:382-410.
13. Hershcovitch MD, Hom DB. Update in wound healing in facial plastic surgery. Arch Facial Plast Surg 2012;14:387-393.
14. Malhotra A, Pelletier MH, Yu Y, Walsh WR. Can platelet-rich plasma (PRP) improve bone healing? A comparison between the theory and experimental outcomes. Arch Orthop Trauma Surg 2013; 133:153-165.
15. Hargrave B, Li F. Nanosecond pulse electric field activation of platelet-rich plasma reduces myocardial infarct size and improves left ventricular mechanical function in the rabbit heart. J Extracorporeal Technol 2012;44:198-204.
16. Sheth U, Simunovic N, Klein G, Fu F, Einhorn TA, Schemitsch E, Ayeni OR, Bhandari M. Efficacy of autologous platelet-rich plasma use for orthopaedic indications: A meta-analysis. J Bone Joint Surg 2012;94:298-307.
17. Maffulli N, Del Buono A. Platelet plasma rich products in musculoskeletal medicine: Any evidence? Surgeon 2012;10: 148-150.
18. Martinez-Zapata MJ, Martí-Carvajal AJ, Solá I, Expósito JA, Bolíbar I, Rodríguez L, Garcia J. Autologous platelet-rich plasma for treating chronic wounds. Cochrane Database Syst Rev 2012;(10): CD006899.
19. Freshwater MF. The use of platelet-rich plasma in plastic surgery remains unproven. J Plast Reconstr Aesth Surg JPRAS 2013;66: 311-312.
20. Steiner H, Hultmark D, Engstrom A, Bennich H, Boman HG. Sequence and specificity of two antibacterial proteins involved in insect immunity. Nature 1981;292:246-248.
21. Yeung AT, Gellatly SL, Hancock RE. Multifunctional cationic host defence peptides and their clinical applications. Cell Mol Life Sci CMLS 2011;68:2161-2176.
22. Yount NY, Yeaman MR. Emerging themes and therapeutic prospects for anti-infective peptides. Annu Rev Pharmacol Toxicol 2012;52: 337-360.
23. Yeaman MR. Platelets in defense against bacterial pathogens. Cell Mol Life Sci 2010;67:525-544.
24. Fitzgerald JR, Foster TJ, Cox D. The interaction of bacterial pathogens with platelets. Nat Rev 2006;4:445-457.
25. Perez F, Hujer AM, Hujer KM, Decker BK, Rather PN, Bonomo RA. Global challenge of multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother 2007;51:3471-3484.
26. Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: Emergence of a successful pathogen. Clin Microbiol Rev 2008;21: 538-582.
27. Kunz AN, Brook I. Emerging resistant Gram-negative aerobic bacilli in hospital-acquired infections. Chemotherapy 2010;56: 492-500.
28. David MZ, Daum RS. Community-associated methicillin-resistant Staphylococcus aureus: Epidemiology and clinical consequences of an emerging epidemic. Clin Microbiol Rev 2010;23:616-687.
29. Moore NM, Flaws ML. Epidemiology and pathogenesis of Pseudomonas aeruginosa infections. Clin Lab Sci 2011;24:43-46.
30. Lister PD, Wolter DJ, Hanson ND. Antibacterial-resistant Pseudomonas aeruginosa: Clinical impact and complex regulation of chromosomally encoded resistance mechanisms. Clin Microbiol Rev 2009;22:582-610.
31. Talbot GH, Bradley J, Edwards JE Jr, Gilbert D, Scheld M, Bartlett JG. Bad bugs need drugs: An update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America. Clin Infect Dis 2006;42:657-668.
32. Hancock REW. 2001. Minimal inhibitory concentration (MIC) Determination for cationic antimicrobial peptides by modified microtitre broth dilution method. Hancock laboratory methods. British Columbia, Canada: Department of Microbiology and Immunology, University of British Columbia. http://www.cmdr.ubc.ca/bobh/methods.htm
33. Metcalfe P, Williamson LM, Reutelingsperger CP, Swann I, Ouwehand WH, Goodall AH. Activation during preparation of therapeutic platelets affects deterioration during storage: A comparative flow cytometric study of different production methods. Br J Haematol 1997;98:86-95.
34. Barbero AM, Frasch HF. Pig and guinea pig skin as surrogates for human in vitro penetration studies: A quantitative review. Toxicol In Vitro 2009;23:1-13.
35. Grice EA, Segre JA. The skin microbiome. Nat Rev 2011;9: 244-253.
36. Medzhitov R, Janeway Jr CA. Decoding the patterns of self and nonself by the innate immune system. Science 2002;296: 298-300.
37. Garcia A, Solar H, Gonzalez C, Zemelman R. Effect of EDTA on the resistance of clinical isolates of Acinetobacter baumannii to the bactericidal activity of normal human serum. J Med Microbiol 2000; 49:1047-1050.
38. Tegla CA, Cudrici C, Patel S, Trippe R 3rd, Rus V, Niculescu F, Rus H. Membrane attack by complement: The assembly and biology of terminal complement complexes. Immunol Res 2011;51:45-60.
39. Cieslik-Bielecka A, Bielecki T, Gazdzik TS, Arendt J, Krol W, Szczepanski T. Autologous platelets and leukocytes can improve healing of infected high-energy soft tissue injury. Transfus Apheresis Sci 2009;41:9-12.
40. Bielecki TM, Gazdzik TS, Arendt J, Szczepanski T, Krol W, Wielkoszynski T. Antibacterial effect of autologous platelet gel enriched with growth factors and other active substances: An in vitro study. J Bone Joint Surg Br 2007;89:417-420.
41. Chen L, Wang C, Liu H, Liu G, Ran X. Antibacterial effect of autologous platelet-rich gel derived from subjects with diabetic dermal ulcers in vitro. J Diabetes Res 2013;2013:269527 (1-5).
42. Drago L, Bortolin M, Vassena C, Taschieri S, Del Fabbro M. Antimicrobial activity of pure platelet-rich plasma against microorganisms isolated from oral cavity. BMC Microbiol 2013; 13:47.
43. Tohidnezhad M, Varoga D, Wruck CJ, Podschun R, Sachweh BH, Bornemann J, Bovi M, Sonmez TT, Slowik A, Houben A, et al. Platelets display potent antimicrobial activity and release human beta-defensin 2. Platelets 2012;23:217-223.